Form 4 for BCDA BioCardia, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-16 · accession 0001437749-22-029317 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-19 | 2022-12-16 | BCDA | Blank Andrew Scott | Dir | A - Grant | $1.68 | +148.8K | 291.7K | +104% | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | A | A | 148,809 | $1.68 | 291,659 | I See Footnote | — | — | (F1) These shares were purchased from the Issuer in a private placement that closed on December 16, 2022. (F2) These shares are held by Andy Blank Revocable Living Trust, of which the Reporting Person serves as trustee. |